Heron Therapeutics Ownership | Who Owns Heron Therapeutics?
Heron Therapeutics Ownership Summary
Heron Therapeutics is owned by 23.46% institutional investors, 0.67% insiders, and 75.87% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.40% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.
HRTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Heron Therapeutics | 23.46% | 0.67% | 75.87% |
| Sector | Healthcare Stocks | 76.79% | 9.87% | 13.34% |
| Industry | Biotech Stocks | 60.64% | 9.74% | 29.62% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rubric capital management lp | 26.71M | 17.40% | $58.77M |
| Blackrock funding, inc. /de | 8.59M | 5.62% | $13.14M |
| Adage capital partners gp | 8.50M | 5.56% | $13.01M |
| Blackrock | 8.33M | 5.51% | $29.14M |
| Vanguard group | 8.16M | 5.34% | $12.48M |
| Velan capital investment management lp | 6.99M | 4.55% | $15.37M |
| Tejara capital | 4.66M | 3.05% | $7.13M |
| Palisade capital management, lp | 3.93M | 2.57% | $6.01M |
| D. e. shaw | 3.72M | 2.44% | $5.70M |
| State street | 3.15M | 2.06% | $4.81M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Velan capital investment management lp | 6.99M | 15.81% | $15.37M |
| Tejara capital | 4.66M | 4.67% | $7.13M |
| Stonepine capital management | 796.10K | 1.70% | $1.75M |
| Jw asset management | 2.29M | 1.67% | $3.51M |
| Congress park capital | 2.46M | 1.36% | $3.76M |
| Orchard capital management | 1.88M | 1.12% | $2.84M |
| Rubric capital management lp | 26.71M | 1.05% | $58.77M |
| Cm management | 700.00K | 0.96% | $1.07M |
| Richmond brothers | 642.34K | 0.63% | $982.78K |
| Clearline capital lp | 1.81M | 0.37% | $2.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 3.08M | 0.01% | 3.08M |
| Millennium management | 1.40M | 0.00% | 1.18M |
| Blackrock | 8.33M | 0.00% | 1.04M |
| Morgan stanley | 767.86K | 0.00% | 568.86K |
| Congress park capital | 2.46M | 1.36% | 477.42K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -6.51M |
| Qube research | - | - | -1.15M |
| Goldman sachs group | 655.16K | 0.00% | -1.05M |
| Renaissance | 1.19M | 0.00% | -819.40K |
| Nuveen asset management | 314.27K | 0.00% | -792.42K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 3.08M | 0.01% | 3.08M | $4.71M |
| Quinn opportunity partners | 380.00K | 0.04% | 380.00K | $581.40K |
| Bridgeway capital management | 300.00K | 0.01% | 300.00K | $459.00K |
| J. goldman & co lp | 270.10K | 0.01% | 270.10K | $413.25K |
| Raymond james financial | 135.72K | 0.00% | 135.72K | $207.66K |
Sold Out
| Holder | Change |
|---|---|
| Allspring global investments | -1.00 |
| Toronto dominion bank | -9.00 |
| Lindbrook capital | -16.00 |
| Ifp advisors | -35.00 |
| Northwestern mutual wealth management | -53.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 7 | -95.81% | 36,006,112 | -68.67% | 23 | 0.41% | 4 | -94.12% | - | -100.00% |
| Dec 31, 2024 | 90 | -48.86% | 38,837,514 | -68.12% | 25 | 0.40% | 37 | -57.95% | 24 | -36.84% |
| Sep 30, 2024 | 175 | -9.79% | 121,805,039 | -6.02% | 79 | 1.08% | 87 | -23.01% | 38 | -2.56% |
| Jun 30, 2024 | 194 | 17.58% | 129,609,462 | 8.61% | 85 | 1.36% | 113 | 59.15% | 39 | -17.02% |
| Mar 31, 2024 | 165 | 5.77% | 119,336,211 | 6.43% | 79 | 1.33% | 71 | -4.05% | 47 | 27.03% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 4.68M | 3.07% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.68M | 3.07% | - |
| Palisade Small Cap Core Equity | 3.33M | 2.19% | 817.01K |
| iShares Russell 2000 ETF | 2.90M | 1.90% | 489.00 |
| Biotech Growth Ord | 2.58M | 1.70% | 2.58M |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.24M | 1.47% | 60.90K |
| Franklin US Small Cap Growth Equity | 1.80M | 1.19% | - |
| Orchard Small Cap Value ESG | 1.67M | 1.09% | - |
| Orchard US Small Cap Value USD Instl 1 | 1.67M | 1.09% | - |
| Orchard Select Small Cap Value | 1.67M | 1.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2023 | Forbes William P | EVP, Chief Development Officer | Buy | $27.25K |
| Nov 16, 2023 | Forbes William P | EVP, Chief Development Officer | Buy | $46.99K |
| Nov 16, 2023 | Collard Craig A | Chief Executive Officer | Buy | $137.97K |
| Nov 16, 2023 | Duarte Ira | EVP, Chief Financial Officer | Buy | $75.60K |
| Jul 21, 2023 | Morgan Adam | - | Buy | $3.41M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
HRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools